OOIR: Observatory of International Research

Papers

(The TQCC of Netherlands Heart Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Chest pain triage: gut feeling or protocol-based care?	39
Older patients with non-ST-elevation myocardial infarction: which treatment strategies do we currently use?	29
A young man with DiGeorge syndrome and tachycardia	16
Reply to ‘Cost-effectiveness of long term left ventricular assist devices’	14
Current gaps in knowledge in inherited arrhythmia syndromes	14
Does it take two to tango?	14
Electrocardiographic ST-segment elevation with prominent R waves in precordial leads	14
Impact of geriatric co-management on outcomes in hospitalised cardiology patients aged 85 and over	14
Changes in demographics, treatment and outcomes in a consecutive cohort who underwent transcatheter aortic valve implantation between 2005 and 2020	13
Omega-3 fatty acids in heart disease—why accurately measured levels matter	13
Renal denervation revisited; should we pay attention?	12
Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?	11
Stacking of antithrombotic drugs in cardiology: evidence-based customisation	11
Cardiac resynchronisation therapy in optima forma	11
No substantial excess all-cause mortality among cardiac implantable electronic device patients during the first COVID‑19 lockdown in the Leiden area	10
Defining left bundle branch block according to the new 2021 European Society of Cardiology criteria	10
The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis	10
Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience	10
2021 European Society of Cardiology guidelines on cardiac pacing and cardiac resynchronisation therapy	10
Data quality and auditing within the Netherlands Heart Registration: using the PCI registry as an example	9
COVID-19-mediated patient delay caused increased total ischaemic time in ST-segment elevation myocardial infarction	9
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial	9
Transcatheter aortic valve replacement: impact of pre-procedural FEops HEARTguide assessment on device size selection in borderline annulus size cases	9
SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades	8
Pulsed field versus cryoballoon ablation for atrial fibrillation: a real-world observational study on procedural outcomes and efficacy	8

A young man with DiGeorge syndrome and tachycardia	8
Characteristics and outcomes of COVID-19 in heart transplantation recipients in the Netherlands	8
Improved prehospital triage for acute cardiac care: results from HART-c, a multicentre prospective study	8
Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms	8
Intramyocardial left anterior descending unroofing using a minimally invasive off-pump approach	7
Demographics and outcomes of patients younger than 75 years undergoing aortic valve interventions in Rotterdam	7
Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry	7
Abnormal repolarisation after a game of Jass	7
The spells of iatrogeny	7
The impact of the multidisciplinary Endocarditis Team on the management of infective endocarditis	6
How often are imaging studies for thoracic aortic aneurysm necessary?	6
A rare finding on computed tomography angiography performed to exclude pulmonary embolism	6
Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist	6
The role of artificial intelligence in coronary CT angiography	6
The Dutch Idiopathic Ventricular Fibrillation Registry: progress report on the quest to identify the unidentifiable	6
Yield of family screening for dilated cardiomyopathy: 10-year experience at a multidisciplinary cardiogenetic outpatient clinic	6
CT is the new standard for the diagnosis of coronary artery disease in daily practice	6
Novel sites for pacemaker lead implantation and different routes for their extraction	6
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants	6
A rare cause of narrow QRS complex tachycardia: the tortoise and the hare	6
Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?	6
‘An ounce of prevention is worth a pound of cure’	5
Referral to and enrolment in cardiac rehabilitation after open-heart surgery in the Netherlands	5
The MIS-HF in clinical practice	5
Percutaneous left stellate ganglion block for refractory ventricular tachycardia in structural heart disease: our single-centre experience	5
Diagnostic accuracy of on-site coronary computed tomography-derived fractional flow reserve in the diagnosis of stable coronary artery disease	5
Data quality within the Netherlands Heart Registration: Ready for prime time?	5
The Netherlands Heart Tissue Bank	5
Atrial fibrillation and what else?	5
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials	5
Pre-hospital rule-out of acute coronary syndrome by modified HEART score assessment including point-of-care troponin	4
CT-derived FFR: beyond anatomy	4
Atrial fibrillation and what else?	4
Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative	4
Is there anything else to fish out of this “fishy” electrocardiogram?	4
A rare electrocardiographic sign of acute inferior myocardial infarction	4
Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer	4
Cardiac rehabilitation for patients with obesity: lessons learned from the OPTICARE XL trial	4
Transcatheter aortic valve implantation under 75 years of age: only for high surgical risk patients; but for how long?	4
Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients	4
Report on outcomes of valve-in-valve transcatheter aortic valve implantation and redo surgical aortic valve replacement in the Netherlands	4
National indication document and aortic valve replacement landscape in the Netherlands	4
An appeal to our government for nationwide policies in the prevention of cardiovascular disease	4
Building a patient-centred nationwide integrated cardiac care registry: intermediate results from the Netherlands	4
Rationale and design of the iCORONARY trial: improving the cost-effectiveness of coronary artery disease diagnosis	4
Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest: an overview of current practice and evidence	4
Welcome from the new editor-in-chief	4
Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?	4
The WOEST 2 registry	4
Sex difference in outcomes after coronary artery bypass grafting: follow-up data of the Netherlands Heart Registration	3

Exercise-based cardiac rehabilitation in stable angina pectoris: a narrative review on current evidence and underlying physiological mechanisms	3
Interventions to prevent postoperative atrial fibrillation in Dutch cardiothoracic centres: a survey study	3
Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)	3
Morning pulmonary artery pressure measurements by CardioMEMS are most stable and recommended for pressure trends monitoring	3
Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial	3
Medications that interact with direct-acting oral anticoagulant exposure	3
Bioprosthetic mitral valve thrombosis	3
Electrocardiographic ST-segment elevation with prominent R waves in precordial leads	3
Cognitive impairment and depression in heart failure: ‘cardiological giants’	3
Desmoplakin cardiomyopathy—an inherited cardiomyopathy presenting with recurrent episodes of acute myocardial injury	3
Towards individualised treatment of out-of-hospital cardiac arrest patients: an update on technical innovations in the prehospital chain of survival	3
Tracing triggers of cardiac remodelling and heart failure	3
Design and rationale of the South-East Netherlands Heart Registry (ZON-HR)	3
Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction	3
ECPELLA as a bridge-to-decision in refractory cardiogenic shock: a single-centre experience	3
Extraction of non-infected redundant pacing and defibrillator leads does not result in better patient outcomes	3
Impact of symptom duration and mechanical circulatory support on prognosis in cardiogenic shock complicating acute myocardial infarction	3
Substance of ‘phantom’ cardiac masses confirmed by therapeutic outcome	3
Biomarkers for cardiovascular risk prediction: from pioneering to evidence-based use in clinical practice	3
Advancing cardiovascular care—key insights from the Netherlands Heart Journal 2024	3